Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


Human Clinical Embryology and Assisted Conception MSc


 

Rare mutation may protect against heart disease

23 May 2016

By Rachel Reeves

Appeared in BioNews 852

A rare genetic mutation reduces the risk of having a heart attack by one-third, a study has found.

The mutation, which substantially lowers levels of non-HDL cholesterol – a marker for heart-disease risk – is already being investigated as potential drug target for preventing heart disease.

'[This is] an important and previously unknown mechanism for modulating non-HDL cholesterol and risk of the most common and deadly forms of heart disease,' said Dr Kári Stefánsson, founder and CEO of deCODE Genetics, who led the research. 'We know we have put our finger on something fundamental when we find a single variant that confers on carriers an average one year of extra lifespan,' he added.

The study, published in the New England Journal of Medicine, matched the genomic data of around 400,000 Icelanders against their medical records. The team found that fewer than one percent of these individuals had a loss-of-function mutation that was associated with significantly lower levels of non-HDL cholesterol. Carriers of the mutation were also 34 percent less likely to develop heart disease, and lived on average one year longer. The researchers could not find any adverse effects of having this mutation.

Dr Stefánsson and his team noticed the same correlation when they looked at the genomes of over 300,000 people of European ancestry, including populations from the Netherlands, Denmark, Germany, New Zealand, the UK and the USA.

The mutation they identified was in the gene ASGR1. Although the researchers do not yet know how the mutation results in a reduction in the risk of heart disease, Amgen – the technology giant that bought deCODE Genetics in 2012 (see BioNews 686) – is already developing drugs to mimic its protective effect.

Researchers found a mutation with a similar effect over a decade ago (see BioNews 758), and Amgen recently developed a drug based on it. The drug was approved by the US Food and Drug Adminstration last year. But Dr Stefánsson believes that this new drug target may be even more effective as he says it reduces heart-disease risk by more than would be expected given its effect on cholesterol alone. 'This is a genetic discovery that is pointing to the possibility of manipulating something other than just blood lipids,' he told Nature News. 'We have no drugs, really, that affect the risk of coronary heart disease that work on alternative mechanisms.'

However, Professor Harlan Krumholz, a cardiology researcher at Yale University in Connecticut, is unconvinced by this claim. 'This study is far from identifying an alternative mechanism of risk reduction for a variant associated with non-HDL reduction,' he told Nature News.

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

06 February 2017 - by Julianna Photopoulos 
About 620,000 people in the UK carry a faulty heart gene that puts them at high risk of sudden death or developing coronary heart disease, the British Heart Foundation has warned...
31 October 2016 - by Arit Udoh 
Screening toddlers for an inherited cholesterol disorder during routine vaccinations could reduce the risk of heart attacks, a study has suggested...
03 October 2016 - by Meetal Solanki 
Genes involved in determining a baby's birthweight may also predispose them to diseases in later life, such as heart disease and type 2 diabetes, a global study has found...
01 August 2016 - by Annabel Slater 
A new stem cell treatment has reversed scarring in heart failure patients by 40 percent, and also improved recovery and survival, a small-scale trial has demonstrated...

14 March 2016 - by Sophie Perry 
A rare genetic mutation that causes high levels of 'good' cholesterol also appears to block its positive effects, increasing the risk of heart disease by 80 percent...
18 November 2014 - by Dr Lanay Tierney 
An inactive copy of a gene associated with cholesterol levels can reduce the risk of a heart attack, according to a study...
23 June 2014 - by Dr Charlotte Warren-Gash 
Four rare gene mutations may protect against heart attacks by lowering levels of a type of fat called triglycerides, according to research in the New England Journal of Medicine.
08 April 2013 - by Dr Greg Ball 
Genes that influence the so-called 'biological age' of cells may also influence susceptibility to many age-related diseases...
13 February 2012 - by Dr Zara Mahmoud 
A sixth of men have a genetic variant which could increase their risk of heart disease by up to 56 percent, according to a recent study...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust
Advertise your products and services HERE - click for further details

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation